INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2012

Magnesium supplementation improved subjective sleep measures and altered serum renin, melatonin, and cortisol in elderly subjects.

In a double-blind randomized clinical trial, 46 elderly subjects received 500 mg magnesium or placebo daily for 8 weeks. Compared with placebo, magnesium supplementation brought about statistically significant increases in sleep time (P = 0.002), sleep efficiency (P = 0.03), serum renin (P < 0.001), and melatonin (P = 0.007). It also significantly decreased Insomnia Severity Index scores (P = 0.006), sleep onset latency (P = 0.02), and serum cortisol concentrations (P = 0.008), although total sleep time did not show a significant difference (P = 0.37).

Study type
Double-blind randomized clinical trial
Who was studied
46 elderly subjects
What was measured
Insomnia severity index, sleep log measures, physical activity, and serum magnesium, renin, melatonin, and cortisol

THE PAPER

The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial.

Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. J Res Med Sci, 2012.

PubMed 23853635 ↗

Nutrients & adequacyBrain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.